Skip to main content

Search form

Medicines for Malaria Venture

Developing antimalarials to save lives

  • Research & Development
    • MMV's pipeline of antimalarial drugs
    • R&D areas of work
      • Next-generation medicines
      • Products for key populations
    • Working with regulators
    • Information for scientists
      • Malaria online course
      • Global health compound design webinars
      • Call for proposals
      • TPPs & TCPs
      • Learning resources for scientists
    • Project of the year award
    • Computational chemistry
    • R&D challenges
  • Access
    • Products & projects
    • Antimalarial drug availability
    • Areas of work
      • Supporting introduction
      • Enhancing reach
      • Informing R&D
      • Gathering market intelligence
    • Antimalarial drug toolkits
      • Artesunate injection dosage & administration
      • Artesunate rectal capsules tool kit
      • Seasonal Malaria Chemoprevention tool kit
    • Access challenges
  • Partnering
    • The PDP model
    • Our partner network
    • Our donors
      • Current donors
      • Past donors
    • Donate to MMV
    • Intellectual property rights (IPR)
    • Clinical centre partners by country
  • Our impact
    • Milestones
    • Malaria stories from the field
    • Antimalarial drugs for children
    • Gender equity
    • Global health security
      • Antimicrobial resistance to antimalarials
      • Malaria and COVID-19
  • About us
    • What we do
      • An overview of our work
      • Our strategic focus
      • Our history
    • People & governance
      • Staff bios
      • Staff interviews
      • Board of Directors
      • MMV North America Board
      • Expert Scientific Advisory Committee
      • Access & Product Management Advisory Committee
      • Global Safety Board
    • Work with us
      • Jobs
      • RFPs/RFIs
    • Policies
    • Diversity at MMV
    • Funding and expenditure
    • FAQs
    • Contact us
  • Malaria & medicines
    • Definitions and symptoms
    • 5 species of Plasmodium parasites
    • Lifecycle of malaria parasite
    • Malaria facts & statistics
    • Malaria treatment
    • History of antimalarial drugs
  • Newsroom
    • News & Press Releases
    • Audio
      • Media interviews
      • Speaking of Malaria podcast
    • Films
    • Infographics
    • Interviews
    • Image slideshows
    • Publications
    • Events
  • MMV Open
    • The Global Health Priority Box
      • About the Global Health Priority Box
      • Supporting information
      • Request the Global Health Priority Box
      • Terms & conditions
    • Malaria Libre
      • Malaria Libre open innovation platform
      • Participate in Malaria Libre
      • Malaria Libre data repository
    • MMVSola
      • About MMVSola
    • Pandemic Response Box
      • About the Pandemic Response Box
      • Request the Pandemic Response Box
      • Supporting information
      • Terms & conditions
    • COVID Box
      • About the COVID Box
      • Supporting information
      • COVID Box terms and conditions
    • Archived projects
      • Pathogen Box
      • Malaria Box
    • MMV Open Team
    • Contact us
  • Home
  • Newsroom
  • News

News

Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
15 found

Australia renews commitment to MMV and R&D for malaria

08 Jun 2018

MMV welcomes Philip Welkhoff, new Malaria Program Director, BMGF

14 Feb 2018

MMV welcomes continued Australian government support

24 Mar 2015

DFID pledges further support for MMV

22 Aug 2013

MMV receives funding to develop drugs to accelerate malaria eradication

22 Aug 2013

The Ian Bathurst Sponsorship Programme

07 Jul 2011

G-FINDER 2010: Good news with a twist in the tail for PDPs

18 Feb 2011

Germany to give €20M to neglected disease research

20 Oct 2010

MMV co-hosted meeting for donors in Barcelona - an unqualified success

24 Mar 2010

Memorial donation in memory of Prof. Dr. Michaela von Freyhold

02 Feb 2010

Outstanding review of MMV by Philanthropy Advisory Service

01 Dec 2009

World Bank Global Program Review (GPR) is published

15 Aug 2008

MMV and other PPPs encourage additional US Government support

11 Jan 2008

World Bank Reviews MMV’s Growth and Progress

18 Jul 2007

Dutch government pledges nearly €7 million to MMV

03 Nov 2006

Follow us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

Previous newsletters

Contact us

  • Tel: +41 22 555 03 00

    • Message us
    • Office directions
© MMV 2023
Website by Manta Ray Media
  • Glossary
  • Disclaimer
  • Privacy
  • Sitemap